How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/chronic-thromboembolic-pulmonary-hypertension.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Chronic thromboembolic pulmonary hypertension — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chronic thromboembolic pulmonary hypertension (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Chronic thromboembolic pulmonary hypertension, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Adempas	RIOCIGUAT	Bayer	Soluble Guanylate Cyclase Stimulator [EPC]	Guanylate cyclase soluble subunit beta-1		2013-01-01
Adempas	Adempas	University of Colorado, Denver		Guanylate cyclase soluble subunit beta-1, cAMP-specific 3',5'-cyclic phosphodiesterase 7B

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Bayer · 1 drug in Chronic thromboembolic pulmonary hypertension
University of Colorado, Denver · 1 drug in Chronic thromboembolic pulmonary hypertension

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Chronic thromboembolic pulmonary hypertension:

Cite this brief

Drug Landscape (2026). Chronic thromboembolic pulmonary hypertension — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/chronic-thromboembolic-pulmonary-hypertension. Accessed 2026-06-10.

Chronic thromboembolic pulmonary hypertension full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing